Canna~Fangled Abstracts Rare Manifestation of ATP1A3 Mutation with Clinical Response to Cannabidiol Letter to the Editor Hamza, Ashique; Sureshbabu, Sachin; Krishnadas, NC; Narayanan, Poornima; Pillai, Deep P;…Freedom WaresOctober 29, 2024
Canna~Fangled Abstracts Cannabidiol: metabolism and clinical efficacy in epileptic patients Review Expert Opin Drug Metab Toxicol. 2024 Mar 11. doi: 10.1080/17425255.2024.2329733. Online ahead of print. Giovanni…Freedom WaresMarch 11, 2024
Canna~Fangled Abstracts Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial JAMA Netw Open. 2021 Sep 1;4(9):e2123930. doi: 10.1001/jamanetworkopen.2021.23930. Ingrid E Scheffer 1 2, Joe Hulihan 3, John Messenheimer 4, Shayma Ali 5, Ngaire Keenan 5, Jim…Freedom WaresSeptember 1, 2021
Canna~Fangled Abstracts The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the Scn1a +/− Mouse Model of Dravet Syndrome Journal List > Front Pharmacol > v.12; 2021 > PMC8165383 Front Pharmacol. 2021; 12: 675128. Published online 2021 May…Freedom WaresMay 17, 2021
Canna~Fangled Abstracts Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome Response to treatment with a highly purified, plant-derived CBD oil-based solution can be seen in…Freedom WaresMarch 20, 2021
Canna~Fangled Abstracts Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects. Neuropsychiatr Dis Treat. 2020 Feb 7;16:381-396. doi: 10.2147/NDT.S203782. eCollection 2020. Morano A1, Fanella M1, Albini…Freedom WaresFebruary 7, 2020
Canna~Fangled Abstracts Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex. Paediatr Drugs. 2020 Jan 8. doi: 10.1007/s40272-019-00376-0. van der Poest Clement E1, Jansen FE1, Braun…Freedom WaresJanuary 8, 2020